Three New Ebola Vaccines Demonstrate Persistent Immune Response
The immunogenicity generated by 3 experimental Ebola vaccines appears to be long-lasting, as it has persisted for at least 2.5 years.
Ebola
Dual Injection Ebola Virus Glycoprotein Synthetic DNA Vaccines Are Protective
A simple intradermalanti-Ebola DNA vaccine may generate strong immunogenicity and induce long-term immune responses in nonhuman primates.
Ebola Outbreak Worst in Congo’s History
Deaths include 163 confirmed Ebola cases, 35 probable cases.
CDC Director Says Congo Ebola Outbreak May Be Uncontainable
Outbreak in North Kivu province is in its fourth month, and there have been nearly 300 cases.
Vaccinations Begin in Congo Ebola Outbreak
First to be vaccinated will be health workers, contacts of confirmed Ebola patients.
New Ebola Outbreak in Congo
Currently, 26 suspected cases of Ebola, including 20 deaths.
In the wake of the Ebola crisis, PAs in Liberia face professional challenges
Physician assistants in Liberia have played a key role in their country’s health care during times of crisis, but they still face professional challenges.
Ebola vaccine trials start in West Africa
Roughly 6,000 health workers will get shots in country hit hard by current outbreak
Governments need to prepare for infectious disease outbreaks
To illustrate the lack of preparedness countries have to address a potential disease outbreak, Bill Gates and associates built an Ebola Treatment Unit (ETU) simulation.
Ebola epidemic may have been started by bat exposure
Ebola epidemics are zoonotic in origin, spreading through contact with bats or larger wildlife.
Next post in Web Exclusives
